BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15581942)

  • 21. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S; Sasaki Y; Iino K
    J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
    Hemida RA; Toson E; Van Doorn HC
    J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placental site trophoblastic tumour: clinical features and management.
    Hassadia A; Gillespie A; Tidy J; Everard R G N J; Wells M; Coleman R; Hancock B
    Gynecol Oncol; 2005 Dec; 99(3):603-7. PubMed ID: 16085293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy.
    Tidy JA; Gillespie AM; Bright N; Radstone CR; Coleman RE; Hancock BW
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):309-12. PubMed ID: 10985885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.
    van Trommel NE; Massuger LF; Verheijen RH; Sweep FC; Thomas CM
    Gynecol Oncol; 2005 Oct; 99(1):6-13. PubMed ID: 16085294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent nonmetastatic gestational trophoblastic disease.
    Kennedy AW
    Semin Oncol; 1995 Apr; 22(2):161-5. PubMed ID: 7740317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
    Goldstein DP; Garner EI; Feltmate CM; Berkowitz RS
    Gynecol Oncol; 2004 Dec; 95(3):421-2. PubMed ID: 15581941
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of gestational trophoblastic disease: results of a cooperative study.
    Fasoli M; Ratti E; Franceschi S; La Vecchia C; Pecorelli S; Mangioni C
    Obstet Gynecol; 1982 Aug; 60(2):205-9. PubMed ID: 6296736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Li L; Wan X; Yang X
    Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases.
    Hwang D; Hancock BW
    J Reprod Med; 2004 Jul; 49(7):559-62. PubMed ID: 15305828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic gestational trophoblastic disease: a case series review.
    Hassadia A; Kew FM; Tidy JA; Wells M; Hancock BW
    J Reprod Med; 2012; 57(7-8):297-300. PubMed ID: 22838244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
    Cole LA; Muller CY
    Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal metastases complicating gestational trophoblastic neoplasia.
    Cagayan MS
    J Reprod Med; 2010; 55(5-6):229-35. PubMed ID: 20626179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.